The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for O Irie


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-based design of substituted piperidines as a new class of highly efficacious oral direct Renin inhibitors.EBI
Novartis Institutes For Biomedical Research
New chemotypes for cathepsin K inhibitors.EBI
Novartis Institutes For Biomedical Research
Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2.EBI
Novartis Institutes For Biomedical Research
Effect of cathepsin K inhibitors on bone resorption.EBI
Novartis Institutes For Biomedical Research
4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors.EBI
Novartis Institutes For Biomedical Research
Discovery of selective and nonpeptidic cathepsin S inhibitors.EBI
Novartis Institutes For Biomedical Research
Novel scaffold for cathepsin K inhibitors.EBI
Novartis Institutes For Biomedical Research
PAR4 agonist peptidesBDB
Bristol-Myers Squibb
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.BDB
Astrazeneca